Treating Bipolar Disorder in the Primary Care Setting: The Role of Aripiprazole

por Manning, J. Sloan, McElroy, Susan L.
Publicado 2009

Adjunctive Methylphenidate in the Treatment of Bulimia Nervosa Co-occurring with Bipolar Disorder and Substance Dependence

por Guerdjikova, Anna I., McElroy, Susan L.
Publicado 2013

Successful Treatment of Binge Eating Disorder With Combination Phentermine/Topiramate Extended Release

por Guerdjikova, Anna I., Fitch, Angela, McElroy, Susan L.
Publicado en Prim Care Companion CNS Disord (2015)

DEPRESSION, ANXIETY, ANGER, AND SOMATIC SYMPTOMS IN PATIENTS WITH BODY DYSMORPHIC DISORDER

por Phillips, Katharine A., Siniscalchi, Jason M., McElroy, Susan L.
Publicado 2004

A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder

por Yee, Karen, Serrano, Daniel, Kando, Judith, McElroy, Susan L.
Publicado en Qual Life Res (2019)

Managing metabolic abnormalities in the psychiatrically ill : a clinical guide for psychiatrists /

por Bermudes, Richard A., Keck, Paul E., McElroy, Susan L.
Publicado 2007.

Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine

por Guerdjikova, Anna I, Mori, Nicole, Casuto, Leah S, McElroy, Susan L
Publicado en Neuropsychiatr Dis Treat (2016)

An Innovative Disease‐Drug‐Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate

por Kalaria, Shamir N., McElroy, Susan L., Gobburu, Jogarao, Gopalakrishnan, Mathangi
Publicado en Clin Transl Sci (2019)

Pharmacological management of binge eating disorder: current and emerging treatment options

por McElroy, Susan L, Guerdjikova, Anna I, Mori, Nicole, O’Melia, Anne M
Publicado 2012

Combination Phentermine–Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study

por Guerdjikova, Anna I., Williams, Stephanie, Blom, Thomas J., Mori, Nicole, McElroy, Susan L.
Publicado en Innov Clin Neurosci (2018)

Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial

por Hudson, James I., McElroy, Susan L., Ferreira-Cornwell, M. Celeste, Radewonuk, Jana, Gasior, Maria
Publicado en JAMA Psychiatry (2017)

Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials

por McElroy, Susan L, Hudson, James, Ferreira-Cornwell, M Celeste, Radewonuk, Jana, Whitaker, Timothy, Gasior, Maria
Publicado en Neuropsychopharmacology (2016)

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder

por Gasior, Maria, Hudson, James, Quintero, Javier, Ferreira-Cornwell, M. Celeste, Radewonuk, Jana, McElroy, Susan L.
Publicado en J Clin Psychopharmacol (2017)

Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Labe...

por Guerdjikova, Anna I., Walsh, Brandon, Shan, Kevin, Halseth, Amy E., Dunayevich, Eduardo, McElroy, Susan L.
Publicado en Adv Ther (2017)

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two R...

por Sheehan, David V., Gasior, Maria, McElroy, Susan L., Radewonuk, Jana, Herman, Barry K., Hudson, James
Publicado en Innov Clin Neurosci (2018)

Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double‐blind, placebo‐controlled trials in adults with binge‐eating disorder

por McElroy, Susan L., Hudson, James I., Gasior, Maria, Herman, Barry K., Radewonuk, Jana, Wilfley, Denise, Busner, Joan
Publicado en Int J Eat Disord (2017)

Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis

por Pi-Sunyer, Xavier, Apovian, Caroline M., McElroy, Susan L., Dunayevich, Eduardo, Acevedo, Lisette M., Greenway, Frank L.
Publicado en Int J Obes (Lond) (2019)

A 52-Week, Double-Blind Evaluation of the Metabolic Effects of Aripiprazole and Lithium in Bipolar I Disorder

por McIntyre, Roger S., McElroy, Susan L., Eudicone, James M., Forbes, Robert A., Carlson, Berit X., Baker, Ross A.
Publicado 2011

Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder: Results of a Pilot Study

por McElroy, Susan L., Guerdjikova, Anna I., Kim, Dennis D., Burns, Colleen, Harris-Collazo, Raúl, Landbloom, Ronald, Dunayevich, Eduardo
Publicado 2013

Statistical methods for testing X chromosome variant associations: application to sex-specific characteristics of bipolar disorder

por Jons, William A., Colby, Colin L., McElroy, Susan L., Frye, Mark A., Biernacka, Joanna M., Winham, Stacey J.
Publicado en Biol Sex Differ (2019)